(Q44952284)

7 December 2017

title

Cytotoxic T lymphocyte antigen-4 gene in breast cancer (English)

1 reference

7 December 2017

0 references

0 references

1

1 reference

7 December 2017

Farshid Yeganeh

2

1 reference

7 December 2017

Tahereh Kalantari

3

1 reference

7 December 2017

Abdul-Rasoul Talei

4

1 reference

7 December 2017

Abdul-Mohammad Pezeshki

5

1 reference

7 December 2017

Mehrnoosh Doroudchi

6

1 reference

7 December 2017

Alamtaj Samsami Dehaghani

7

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

Breast Cancer Research and Treatment

7 December 2017

published in

1 reference

7 December 2017

volume

86

1 reference

7 December 2017

issue

1

1 reference

7 December 2017

page(s)

1-7

1 reference

https://scigraph.springernature.com/pub.10.1023/b:brea.0000032918.89120.8e

7 December 2017

exact match

0 references

cites work

CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032918.89120.8E

Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032918.89120.8E

Co-stimulation in T cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032918.89120.8E

7 January 2021

An Mse I RFLP in the human CTLA4 promotor

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032918.89120.8E

7 January 2021

Association of a novel point mutation (C159G) of the CTLA4 gene with type 1 diabetes in West Africans but not in Chinese

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032918.89120.8E

7 January 2021

Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032918.89120.8E

7 January 2021

Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032918.89120.8E

7 January 2021

Regulation of surface and intracellular expression of CTLA-4 on human peripheral T cells

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032918.89120.8E

7 January 2021

CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032918.89120.8E

7 January 2021

Molecular basis of T cell inactivation by CTLA-4

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032918.89120.8E

7 January 2021

CD4+CD25high regulatory cells in human peripheral blood

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032918.89120.8E

7 January 2021

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032918.89120.8E

7 January 2021

Enhancement of antitumor immunity by CTLA-4 blockade

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032918.89120.8E

7 January 2021

Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accomp

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032918.89120.8E

7 January 2021

Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: comparison of prophylaxis and therapy

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032918.89120.8E

7 January 2021

Low penetrance genes associated with increased risk for breast cancer.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032918.89120.8E

7 January 2021

Association between the T29-->C polymorphism in the transforming growth factor beta1 gene and breast cancer among elderly white women: The Study of Osteoporotic Fractures.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032918.89120.8E

7 January 2021

A simple salting out procedure for extracting DNA from human nucleated cells

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032918.89120.8E

7 January 2021

Germline mutations in the neurofibromatosis type 2 tumour suppressor gene

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032918.89120.8E

7 January 2021

Genetic association of Ctla-4 to myasthenia gravis with thymoma

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032918.89120.8E

7 January 2021

Association of asthma severity and bronchial hyperresponsiveness with a polymorphism in the cytotoxic T-lymphocyte antigen-4 gene

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032918.89120.8E

7 January 2021

Cytotoxic T lymphocyte antigen 4 gene polymorphism confers susceptibility to type 1 diabetes in Japanese children: analysis of association with HLA genotypes and autoantibodies

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032918.89120.8E

7 January 2021

An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032918.89120.8E

7 January 2021

CTLA-4 gene polymorphism in promoter and exon-1 regions in Chinese patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032918.89120.8E

7 January 2021

The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032918.89120.8E

7 January 2021

Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032918.89120.8E

7 January 2021

Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032918.89120.8E

7 January 2021

Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032918.89120.8E

7 January 2021

Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032918.89120.8E

7 January 2021

Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032918.89120.8E

7 January 2021

10.1023/B:BREA.0000032918.89120.8E

Identifiers

DOI

1 reference

Dimensions Publication ID

7 December 2017

1031083609

0 references

1 reference